Quick Answer
Medirom Healthcare Technologies Inc. reported Cash and Equivalents of $2.09 million for fiscal year 2024.
Medirom Healthcare Technologies Inc. Cash and Equivalents — Annual History
| Fiscal Year | Cash and Equivalents | YoY Change |
|---|---|---|
| 2024 | $2.09M | -98.0% |
| 2023 | $106.35M | -82.4% |
| 2022 | $605.45M | +63.4% |
| 2021 | $370.62M | -74.3% |
| 2020 | $1.44B | +180.3% |
| 2019 | $513.62M | — |
- Medirom Healthcare Technologies Inc. showed a decrease of -98.0% in Cash and Equivalents compared to the prior fiscal year.
- Over the 2019–2024 period, Medirom Healthcare Technologies Inc.’s cash and equivalents has declined by 99.6% (from $513.62 million to $2.09 million).
- The most recent figure is from Medirom Healthcare Technologies Inc.’s fiscal year 2024 report (Form 20-F), filed with the SEC on April 29, 2025.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: